✦ LIBER ✦

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Scribed by Paty, D. W.; Li, D.K.B.

Book ID: 126767677
Publisher: Lippincott Williams and Wilkins
Year: 1993
Tongue: English
Weight: 759 KB
Volume: 43
Category: Article
ISSN: 0028-3878
DOI: 10.1212/WNL.43.4.662

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Interferon beta-1b is effective in relap

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis: II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Paty, D. W.; Li, D.K.B. 📂 Article 📅 1993 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 759 KB

We performed yearly MRI analyses on 327 of the total 372 patients in a multicenter, randomized, double-blind, placebo-controlled trial of interferon beta-1b (IFNB). Clinical results are presented in the preceding companion paper. Baseline MRI characteristics were the same in all treatment groups. Fi

Intravenous immunoglobulin treatment in

Intravenous immunoglobulin treatment in relapsing-remitting multiple sclerosis: A randomized, double-blind multicenter, placebo-controlled trial

✍ A. Achiron; R. Gilad; S. Hassin; Y. Barak; U. Gabbay; I. Ziv; Y. Goldhamer; E. M 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 144 KB

Randomized double-blinded placebo contro

Randomized double-blinded placebo controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24 months clinical and MRI results

✍ I. Millefiorim; C. Gasperini 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Simvastatin treatment in patients with r

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

✍ Togha, M.; Karvigh, S. A.; Nabavi, M.; Moghadam, N. B.; Harirchian, M. H.; Sahra 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 140 KB

Simvastatin treatment in patients with r

Simvastatin treatment in patients with relapsing-remitting multiple sclerosis receiving interferon beta 1a: a double-blind randomized controlled trial

✍ Togha, M.; Karvigh, S. A.; Nabavi, M.; Moghadam, N. B.; Harirchian, M. H.; Sahra 📂 Article 📅 2010 🏛 SAGE Publications 🌐 English ⚖ 140 KB

Magnetic resonance imaging results of th

Magnetic resonance imaging results of the PRISMS trial: A randomized, double-blind, placebo-controlled study of interferon-β1a in relapsing-remitting multiple sclerosis

✍ David K. B. Li; Donald W. Paty 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 2 views

The PRISMS (Prevention of Relapses and Disability by Interferon-␤1a Subcutaneously in Multiple Sclerosis) trial was a doubleblind, randomized, multicenter, phase III, placebo-controlled study of interferon-␤1a in 560 patients from 22 centers in 9 countries with clinically definite or laboratory-supp